Abstract
Abdominal aortic aneurysm (AAA), a common disease among elderly individuals, involves the progressive dilatation of the abdominal aorta as a consequence of degeneration. The mechanisms of AAA formation, development and rupture are largely unknown. Surgical repair is the only available method of treatment since the lack of knowledge regarding the pathogenesis of AAA has hindered the development of suitable medical treatments, particularly the development of drugs. In this review, we describe the inflammatory cells and proteases that may be involved in the formation and development of AAA. This knowledge can contribute to the development of new drugs for AAA.
Keywords: Abdominal aortic aneurysm, inflammatory cells, proteases, extracellular matrix, macrophages, atherosclerosis.
Graphical Abstract
Current Drug Targets
Title:Inflammatory Cells and Proteases in Abdominal Aortic Aneurysm and its Complications
Volume: 19 Issue: 11
Author(s): Haiying Jiang, Takeshi Sasaki, Enze Jin, Masafumi Kuzuya and Xian Wu Cheng*
Affiliation:
- Department of Cardiology and Heart Center/Hypertension, Yanbian University Hospital, Yanji 133000, Jilin Prov.,China
Keywords: Abdominal aortic aneurysm, inflammatory cells, proteases, extracellular matrix, macrophages, atherosclerosis.
Abstract: Abdominal aortic aneurysm (AAA), a common disease among elderly individuals, involves the progressive dilatation of the abdominal aorta as a consequence of degeneration. The mechanisms of AAA formation, development and rupture are largely unknown. Surgical repair is the only available method of treatment since the lack of knowledge regarding the pathogenesis of AAA has hindered the development of suitable medical treatments, particularly the development of drugs. In this review, we describe the inflammatory cells and proteases that may be involved in the formation and development of AAA. This knowledge can contribute to the development of new drugs for AAA.
Export Options
About this article
Cite this article as:
Jiang Haiying , Sasaki Takeshi , Jin Enze , Kuzuya Masafumi and Cheng Wu Xian*, Inflammatory Cells and Proteases in Abdominal Aortic Aneurysm and its Complications, Current Drug Targets 2018; 19 (11) . https://dx.doi.org/10.2174/1389450119666180531103458
DOI https://dx.doi.org/10.2174/1389450119666180531103458 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting the Inflammatory Response in Healing Myocardial Infarcts
Current Medicinal Chemistry Glaucoma Disease: A Survey
Current Medical Imaging Rheumatoid Arthritis: Genetic Variants as Biomarkers of Cardiovascular Disease
Current Pharmaceutical Design The Effect of Anti-B-cell Therapy on the Development of Atherosclerosis in Patients with Rheumatoid Arthritis
Current Pharmaceutical Design Newly Diagnosed Dementia and Increased Risk of Hemorrhagic Stroke: A Nationwide Population-based Study
Current Alzheimer Research Mitochondrial Triglyceride Transfer Protein Inhibition: New Achievements in the Treatment of Dyslipidemias
Current Pharmaceutical Design Redox Control of Cardiovascular Homeostasis by Angiotensin II
Current Pharmaceutical Design Interleukin-1 and Occlusive Arterial Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Statins and Infrainguinal Vascular Bypass Procedures
Current Vascular Pharmacology Prevention of Endothelial Dysfunction and Cardiovascular Disease by n-3 Fatty Acids-Inhibiting Action on Oxidative Stress and Inflammation
Current Pharmaceutical Design Crosslinked, Polymerized, and PEG-Conjugated Hemoglobin-Based Oxygen Carriers: Clinical Safety and Efficacy of Recent and Current Products
Current Drug Discovery Technologies Coronary Stent Fracture: A Recently Appreciated Phenomenon with Clinical Relevance
Current Cardiology Reviews Modulation of Collagen Turnover in Cardiovascular Disease
Current Pharmaceutical Design Demystifying the ACE Polymorphism: From Genetics to Biology
Current Pharmaceutical Design COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases
Current Rheumatology Reviews Reactive Oxygen Species in Pathogenesis of Atherosclerosis
Current Pharmaceutical Design Significant Association of CXCL12 rs1746048 with LDL-C Level in Intracranial Aneurysms
Current Neurovascular Research Glucocorticoids and the Cardiovascular System: State of the Art
Current Pharmaceutical Design Patent Selections:
Recent Patents on Cardiovascular Drug Discovery Intracranial Aneurysms; In Need of Early Diagnostic and Treatment Using Bio- and Nanotechnology
Current Medicinal Chemistry